Down-regulated gene expression spectrum and immune responses changed during the disease progression in COVID-19 patients release_e72vjipe5bafjduladpgnmuwuy

by Yabo Ouyang, Jiming Yin, Wenjing Wang, Hongbo Shi, Ying Shi, Bin Xu, Luxin Qiao, Yingmei Feng, Lijun Pang, Feili Wei, Xianghua Guo, Ronghua Jin (+1 others)

Published in Clinical Infectious Diseases by Oxford University Press (OUP).

2020   Volume 71, Issue 16, p2052-2060

Abstract

<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> WHO characterizes novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a pandemic. Here, we investigated the clinical, cytokine levels, T cell proportion and related gene expression occurring in COVID-19 patients on admission and after intial treatment. </jats:sec> <jats:sec> <jats:title>Methods</jats:title> 11 patients diagnosed as COVID-19 with similar initial treatment regimen were enrolled in the hospital. Plasma cytokines, CyTOF and microfluidic qPCR for gene expression were conducted. </jats:sec> <jats:sec> <jats:title>Results</jats:title> 5 mild and 6 severe patients were included. Cough and fever were the top symptoms in the 11 COVID-2019 cases. The elder age, more neutrophils numbers and higher C-reactive protein level were found in severe cases. IL-10 level was significantly varied with disease progression and treatment. The decreased T cell proportions were observed in COVID-19 patients especially in severe cases, and all elevated to normal in mild patiens after initial treatment but only CD4+T cells return to normal in severe cases. The number of DEGs increased with the disease progress, and decreased after initial treatment. All down-regulated DEGs in severe cases mainly involved in Th17 cell differentiation, cytokine-mediated signaling pathway and T cell activation. After initial treatmen in severe cases, MAP2K7 and SOS1 were upregulated relative to that on admission. </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> Our findings show a decreased T cell proportion with down-regulated gene expression related to T cell activation and differentiation were occurred in COVID-19 severe patients, which may help to provide effective treatment strategies for COVID-19 . </jats:sec>
In application/xml+jats format

Archived Files and Locations

application/pdf  1.5 MB
file_kgqwkovkyvcwhoove3ecxlpkf4
watermark.silverchair.com (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2020-04-20
Language   en ?
DOI  10.1093/cid/ciaa462
PubMed  32307550
PMC  PMC7188184
Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  1058-4838
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: f7cbeb56-ac59-49e6-ade8-477aafd4d705
API URL: JSON